Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-07 |
mRNA | APBB1IP | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-08 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-09 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
mRNA | ARHGAP9 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-07 |
mRNA | SH2D3C | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-08 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.39 | 9e-13 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.39 | 7e-14 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-06 |